PressRelease

Drugs for Vulvovaginal Candidiasis Market by Effect Factors Analysis, Technology Progress and Size Estimation 2019-2024

Drugs

Drugs for Vulvovaginal Candidiasis Market Research report forecast from 2019-2024 gives in-depth information of top Key players in their respective regions/countries. This report provides overview of Drugs for Vulvovaginal Candidiasis Market by Defining, specifying, Classifying the reason for growth factor. The report includes Manufactures, Types and Applications.

Ask a Sample of Drugs for Vulvovaginal Candidiasis market research report from- https://www.absolutereports.com/enquiry/request-sample/13860724

About Drugs for Vulvovaginal Candidiasis:

The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for at least 72 hours after the ingestion of a single 150-mg tablet.Some women with recurrent candidal infections opt for treatment with over-the-counter (OTC) medications, which generally are highly effective for candidiasis. Preparations for intravaginal administration of butoconazole, clotrimazole, miconazole, and tioconazole are available OTC.

Drugs for Vulvovaginal Candidiasis Market Manufactures:

Bayer,Perrigo,J & J,Pfizer,Bristol-Myers Squibb,Effik,Teva,Sanofi,Cisen Pharmaceutical,Kingyork Group,   

Drugs for Vulvovaginal Candidiasis Market Types:

  • Cream
  • Pessary
  • Other

    Drugs for Vulvovaginal Candidiasis Market Applications:

  • Hospital & Clinic
  • Pharmacy

    Browse TOC and Charts & Tables of Drugs for Vulvovaginal Candidiasis Market Research Report available at- https://www.absolutereports.com/global-drugs-for-vulvovaginal-candidiasis-market-2019-by-manufacturers-regions-type-and-application-forecast-to-2024-13860724   

    Scope of Report:

  • The classification of Drugs for Vulvovaginal Candidiasis includes Cream, Pessary and other. The proportion of Cream in 2017 is about 47.2%, and the proportion of Pessary in 2017 is about 34.1%.
  • The drugs for Vulvovaginal Candidiasis are Miconazole, Clotrimazole, Fluconazole, Econazole and Other, market share of Fluconazole is about 24.5% in 2017.
  • Drugs for Vulvovaginal Candidiasis is application in Hospital & Clinic and Pharmacy. The most of Drugs for Vulvovaginal Candidiasis is used in Pharmacy, and the market share in 2016 is about 59%.
  • The worldwide market for Drugs for Vulvovaginal Candidiasis is expected to grow at a CAGR of roughly 2.1% over the next five years, will reach 870 million US$ in 2024, from 770 million US$ in 2019, according to a new GIR (Global Info Research) study.
  • This report focuses on the Drugs for Vulvovaginal Candidiasis in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

    The objectives of Drugs for Vulvovaginal Candidiasis Market included in report are:

    • Industry Overview of Drugs for Vulvovaginal Candidiasis
    • Manufacturing Cost Structure Analysis of Drugs for Vulvovaginal Candidiasis
    • Technical Data and Manufacturing Plants Analysis of Drugs for Vulvovaginal Candidiasis
    • Global Drugs for Vulvovaginal Candidiasis Overall Market Overview
    • Drugs for Vulvovaginal Candidiasis Regional Market Analysis
    • Global 2013-2019 Drugs for Vulvovaginal Candidiasis Segment Market Analysis (by Type)
    • Global 2013-2019 Drugs for Vulvovaginal Candidiasis Segment Market Analysis (by Application)
    • Major Manufacturers Analysis of Drugs for Vulvovaginal Candidiasis
    • Development Trend of Analysis of Drugs for Vulvovaginal Candidiasis Market
    • Drugs for Vulvovaginal Candidiasis Marketing Type Analysis

    No.of Pages: 117

    Purchase Full Report at $ 3480 (Single User Licence) at: https://www.absolutereports.com/purchase/13860724

    Contact Us:

    Name: Ajay More

    Organization: Absolute Reports

    Phone: +1424 253 0807/ +44 203 239 8187

    Mail at: [email protected]